INOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a ...

Genital human papillomavirus is the most common sexually transmitted infection in the United States and is thought to be ...

HIV is a manageable chronic condition. With treatment, people living with HIV can have long and healthy lives. However, if left untreated, it can cause a weakened immune system or acquired immune ...

Discover how HPV silently triggers throat cancer, why vaccination rates are dropping, and what medical experts say about ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

HPV self-sampling improves cervical cancer screening accessibility, offering comfort, privacy, and early detection for ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

SAN DIEGO - Dare Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company focused on women's health, has been awarded a Notice of Award of a grant from the National Institute of Allergy and ...

His team is also exploring whether recently developed drugs that block YAP function may provide new treatment options for oral cancers. He adds that the research paves the way for the development of ...

Course- based Undergraduate Research Experiences (CUREs) by incorporating nine essential elements of research, relevance, scientific background, hypothesis development, research proposal, all aspects ...

For women over 30, co-testing with a Pap smear and HPV test, or HPV testing alone, is recommended every five years. As for treatment options, surgery remains the most effective option for early-stage ...